Stay updated with breaking news from Dbv Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report published on Sunday. The firm issued a sell rating on the stock. A number of other research firms have also weighed in on DBVT. Societe Generale raised shares of DBV Technologies from a hold rating to a buy rating in […]
StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Sunday. The firm issued a sell rating on the stock. Other equities research analysts have also recently issued research reports about the company. JMP Securities reissued a market outperform rating and issued a $4.00 price objective on shares […]
DBV Technologies (NASDAQ:DBVT – Get Rating) and Solid Biosciences (NASDAQ:SLDB – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, dividends and profitability. Risk and Volatility DBV Technologies has a beta of […]
StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a research report sent to investors on Saturday morning. The firm issued a sell rating on the stock. A number of other equities research analysts have also weighed in on DBVT. HC Wainwright reaffirmed a buy rating and set a $10.00 price […]
DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) has received a consensus recommendation of “Hold” from the six research firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average 1-year target price among brokers that […]